Diabetic drug shown to reduce the risk of heart disease in non-diabetic patients
(University of Dundee) Metformin could reverse the harmful thickening of heart muscle that leads to cardiovascular disease, according to researchers at the University of Dundee.The findings of the study if implemented could potentially save the NHS billions of pounds every year and offer hope for millions of patients across the globe. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 16, 2019 Category: International Medicine & Public Health Source Type: news

Metformin May Cut Risk for Prematurity, Miscarriage in PCOS
MONDAY, April 15, 2019 -- In pregnant women with polycystic ovary syndrome (PCOS), metformin treatment from the late first trimester until delivery might reduce the risk for late miscarriage and preterm birth but does not prevent gestational... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 15, 2019 Category: Pharmaceuticals Source Type: news

Could Metformin Before Conception Be the Answer in PCOS? Could Metformin Before Conception Be the Answer in PCOS?
Metformin ups likelihood of full-term births, reduces late miscarriages in women with PCOS, but doesn't impact gestational diabetes. Study also hints giving drug pre-pregnancy could be beneficial.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - April 10, 2019 Category: Endocrinology Tags: Diabetes & Endocrinology News Source Type: news

Metformin for NAFLD and NASH Metformin for NAFLD and NASH
Should metformin be recommended in patients with NAFLD or NASH? Find the evidence-based answer here.American Family Physician (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 5, 2019 Category: Consumer Health News Tags: Family Medicine/Primary Care Journal Article Source Type: news

Safe and Cheap Metformin Prevents Type 2 Diabetes Over 15 Years Safe and Cheap Metformin Prevents Type 2 Diabetes Over 15 Years
In long-term follow-up, Diabetes Prevention Program participants randomized to metformin during the trial continue to have lower rates of developing type 2 diabetes.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - April 2, 2019 Category: Endocrinology Tags: Diabetes & Endocrinology News Source Type: news

Oral Semaglutide Tops Sitagliptin for Cutting HbA1c, Weight in T2D
(MedPage Today) -- Positive results from PIONEER 3 trial in diabetic patients who aren't responding to metformin with or without sulfonylurea (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - March 24, 2019 Category: Cardiology Source Type: news

8 Science-Backed Ways to Prevent Heart Attacks, According to New Guidelines
Experts have issued a new set of guidelines on the best ways to prevent first heart attacks, strokes and heart failure — and for the first time, they focus squarely on the patient. The new guidelines recognize how doctors can support people to not only address their medical risk factors, but also to change their behaviors and lifestyles in order to reduce their risk. The latest revisions to the guidelines, issued by the American College of Cardiology (ACC) and the American Heart Association (AHA), were announced at the annual meeting of the ACC. They are intended to help doctors figure out a patient’s risk of h...
Source: TIME: Health - March 18, 2019 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized Heart Disease Source Type: news

Daily Aspirin No Longer Recommended To Prevent Heart Attacks In Older Adults
(CNN) — If you’re a healthy older adult looking for ways to reduce your risk of heart attack and stroke, don’t turn to that age-old standby: daily low-dose aspirin. It’s no longer recommended as a preventative for older adults who don’t have a high risk or existing heart disease, according to guidelines announced Sunday by the American College of Cardiology and the American Heart Association. “For the most part, we are now much better at treating risk factors such as hypertension, diabetes and especially high cholesterol,” said North Carolina cardiologist Dr. Kevin Campbell, who wa...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - March 18, 2019 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health News aspirin CNN Source Type: news

Diabetes med may ease chemo side effects for breast cancer patients
A class of diabetes drugs that includes metformin could offer relief to some breast cancer patients from dangerous cardiovascular side effects of chemotherapy. (Source: Health News - UPI.com)
Source: Health News - UPI.com - March 14, 2019 Category: Consumer Health News Source Type: news

Type 2 Diabetes Ups Odds of VTE, Metformin Reduces It Type 2 Diabetes Ups Odds of VTE, Metformin Reduces It
In a new study, VTE was nearly three times as common in type 2 diabetes as in type 1 or in people without diabetes. And metformin reduced the risk of VTE.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - March 8, 2019 Category: Endocrinology Tags: Diabetes & Endocrinology News Source Type: news

Proposal to lower threshold for hypertension treatment
NICE proposals could benefit thousands of patients Related items fromOnMedica Women less likely than men to achieve CHD targets Too few women take part in many CVD clinical trials NICE rejects arguments against wider statin use Adding insulin to metformin linked to higher mortality US expert group updates statins recommendations (Source: OnMedica Latest News)
Source: OnMedica Latest News - March 8, 2019 Category: UK Health Source Type: news

Metformin may reduce miscarriage risk in polycystic ovary syndrome patients
Research, published inThe Lancet Diabetes& Endocrinology, suggests that metformin reduces the risk of miscarriage in pregnant women with polycystic ovary syndrome. Healio (Source: Society for Endocrinology)
Source: Society for Endocrinology - February 25, 2019 Category: Endocrinology Source Type: news

Why Food Could Be the Best Medicine of All
When Tom Shicowich’s toe started feeling numb in 2010, he brushed it off as a temporary ache. At the time, he didn’t have health insurance, so he put off going to the doctor. The toe became infected, and he got so sick that he stayed in bed for two days with what he assumed was the flu. When he finally saw a doctor, the physician immediately sent Shicowich to the emergency room. Several days later, surgeons amputated his toe, and he ended up spending a month in the hospital to recover. Shicowich lost his toe because of complications of Type 2 diabetes as he struggled to keep his blood sugar under control. He wa...
Source: TIME: Health - February 23, 2019 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized health Nutrition Source Type: news

Scientific literature supports using turmeric as an ideal drug alternative for treating and preventing Type 2 diabetes
(Natural News) Diabetes treatments tend to fall into one of two categories: medications such as Metformin or lifestyle habits like exercise and a proper diet. However, there is one category that deserves just as much consideration, if not more, and that’s herbal remedies – and turmeric in particular. With 30.3 million Americans suffering from diabetes... (Source: NaturalNews.com)
Source: NaturalNews.com - February 11, 2019 Category: Consumer Health News Source Type: news

Go ahead for first add-on tablet to insulin treatment for type 1 diabetes
European regulator recommends dapagliflozin for those with poor blood glucose control despite best efforts Related items fromOnMedica Use of DPP-4 inhibitors associated with increased risk of IBD Adding insulin to metformin linked to higher mortality Draft diabetes guidance too heavily focused on cost, protests industry MHRA tightens licence restrictions on valproate for women Withdrawn valsartan meds not linked to short-term cancer risk (Source: OnMedica Latest News)
Source: OnMedica Latest News - February 5, 2019 Category: UK Health Source Type: news

Don ’t use barrier creams with FreeStyle Libre sensor
MHRA urges patients to report skin reactions to sensor adhesive and see their doctor or nurse Related items fromOnMedica Type 2 diabetes in 10 times more young people than realised Adding insulin to metformin linked to higher mortality Child type 2 diabetes is a ‘wake-up call’ to the nation Scotland reveals target of halving child obesity by 2030 Sugar not saturated fat is the major issue for CVD (Source: OnMedica Latest News)
Source: OnMedica Latest News - January 30, 2019 Category: UK Health Source Type: news

5 New Neurology Studies' Practice-Changing Implications 5 New Neurology Studies' Practice-Changing Implications
Dr Christoph Diener on aspirin's rapidly declining reputation, a new use for metformin, and other recent findings.Medscape Neurology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 29, 2019 Category: Consumer Health News Tags: Neurology & Neurosurgery Commentary Source Type: news

Metformin vs. Insulin
Title: Metformin vs. InsulinCategory: MedicationsCreated: 1/18/2019 12:00:00 AMLast Editorial Review: 1/18/2019 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - January 18, 2019 Category: Drugs & Pharmacology Source Type: news

Experimental Drug Could Help In Type 2 Diabetes
Researchers found that the compound -- dubbed TTP399 for now -- improved patients' blood sugar control when it was added to the standard medication metformin for six months. (Source: WebMD Health)
Source: WebMD Health - January 17, 2019 Category: Consumer Health News Source Type: news

Ertugliflozin Seems Safe, Effective for Type 2 Diabetes Treatment
THURSDAY, Jan. 17, 2019 -- Ertugliflozin appears safe and effective at improving long-term glycemic control among adults with type 2 diabetes mellitus (T2DM) inadequately controlled on metformin, according to a study published online Jan. 7 in... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 17, 2019 Category: Pharmaceuticals Source Type: news

Cholesterol, Diabetes, BP Meds May Help Serious Mental Illness Cholesterol, Diabetes, BP Meds May Help Serious Mental Illness
Drug-repurposing research suggests a role for statins, calcium channel blockers, and metformin in treating schizophrenia and other serious mental illness.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - January 16, 2019 Category: Endocrinology Tags: Psychiatry News Source Type: news

Common Heart, Diabetes Meds May Aid Mental Illness
Specifically, the benefit was seen when patients were taking: statins, which lower cholesterol; calcium channel blockers, a group of blood pressure drugs; or the oral diabetes drug metformin, the study findings showed. (Source: WebMD Health)
Source: WebMD Health - January 10, 2019 Category: Consumer Health News Source Type: news

Common Somatic Meds May Offer Benefits in Psychosis
(MedPage Today) -- Statins, metformin tied to reduced rates of psych hospitalization, self-harm (Source: MedPage Today Neurology)
Source: MedPage Today Neurology - January 9, 2019 Category: Neurology Source Type: news

One in 37 type 2 diabetics taking a commonly prescribed drug will have a heart attack
A study by Northwestern University found that sulfonylureas and basal insulin - which are given to patients if metformin fails - make them more at risk than the newer drug class DPP-4 inhibitors. (Source: the Mail online | Health)
Source: the Mail online | Health - December 21, 2018 Category: Consumer Health News Source Type: news

Metformin vs. Janumet
Title: Metformin vs. JanumetCategory: MedicationsCreated: 12/21/2018 12:00:00 AMLast Editorial Review: 12/21/2018 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - December 21, 2018 Category: Drugs & Pharmacology Source Type: news

Metformin (Glucophage) vs. Glipizide (Glucotrol)
Title: Metformin (Glucophage) vs. Glipizide (Glucotrol)Category: MedicationsCreated: 12/21/2018 12:00:00 AMLast Editorial Review: 12/21/2018 12:00:00 AM (Source: MedicineNet Diabetes General)
Source: MedicineNet Diabetes General - December 21, 2018 Category: Endocrinology Source Type: news

Interview with Dr Ioannis Gallos lead author of the updated Uterotonic agents for preventing postpartum haemorrhage: a network meta ‐analysis
The aim of thisCochrane Review was to find out which drug is most effective in preventing excessive blood loss at childbirth and has the least side effects. The authors collected and analysed all the relevant studies to answer this question.The lead author of this review is Dr Ioannis Gallos. He is a Clinician Scientist in University of Birmingham and Honorary Consultant in Obstetrics& Gynaecology for Birmingham Women ’s Hospital. Ioannis obtained his Degree in Medicine and Surgery (DMS) cum laude from the University of Rome, Italy. He subsequently trained in Obstetrics& Gynaecology in the UK and sub-speciali...
Source: Cochrane News and Events - December 20, 2018 Category: Information Technology Authors: Katie Abbotts Source Type: news

Metformin vs. Lantus
Title: Metformin vs. LantusCategory: MedicationsCreated: 12/20/2018 12:00:00 AMLast Editorial Review: 12/20/2018 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - December 20, 2018 Category: Drugs & Pharmacology Source Type: news

Metformin vs. Januvia
Title: Metformin vs. JanuviaCategory: MedicationsCreated: 12/20/2018 12:00:00 AMLast Editorial Review: 12/20/2018 12:00:00 AM (Source: MedicineNet Diabetes General)
Source: MedicineNet Diabetes General - December 20, 2018 Category: Endocrinology Source Type: news

Metformin vs. Victoza
Title: Metformin vs. VictozaCategory: MedicationsCreated: 12/19/2018 12:00:00 AMLast Editorial Review: 12/19/2018 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - December 19, 2018 Category: Drugs & Pharmacology Source Type: news

Diabetes drug could be used to treat common heart failure syndrome, study suggests
(Rockefeller University Press) Researchers at the University of Arizona have discovered that metformin, a drug commonly used to treat type 2 diabetes, might also be used to treat a common heart failure syndrome that is predicted to affect over 8 percent of people ages 65 or older by the year 2020. The study, which was published December 19 in the Journal of General Physiology, shows that metformin relaxes a key heart muscle protein called titin, allowing the heart to properly fill with blood before pumping it around the body. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 19, 2018 Category: International Medicine & Public Health Source Type: news

Metformin and B12 Deficiency: A Bigger Problem Than We Thought Metformin and B12 Deficiency: A Bigger Problem Than We Thought
New evidence suggests that preventing vitamin B12 deficiency could reduce peripheral neuropathy in patients on metformin.Medscape Internal Medicine (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 18, 2018 Category: Consumer Health News Tags: Internal Medicine Commentary Source Type: news

Diabetes and hypertension drugs may synergise to treat cancer
Research, published in Cell Reports, suggests the combination of the diabetes drug metformin with the antihypertensive drug syrosingopine is effective at killing cancer cells.Medical News Today (Source: Society for Endocrinology)
Source: Society for Endocrinology - December 17, 2018 Category: Endocrinology Source Type: news

Medical News Today: Diabetes and hypertension drug combo kills cancer cells
New research finds that combining the drug metformin with an antihypertensive drug cuts off the energy supply to cancer cells and inhibits tumor growth. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - December 15, 2018 Category: Consumer Health News Tags: Cancer / Oncology Source Type: news

Metformin Does Not Improve Pregnancy Outcomes in Heavy Women Metformin Does Not Improve Pregnancy Outcomes in Heavy Women
Adding metformin to diet and lifestyle advice does not improve pregnancy or birth outcomes in women who are overweight or obese, according to a clinical trial from Australia.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 14, 2018 Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news

Statins are being overprescribed, study suggests
The risks of statins for primary prevention are greater than the benefits for many patients Related items fromOnMedica Withdrawn valsartan meds not linked to short-term cancer risk Direct oral anticoagulants as safe as warfarin after VTE Too few women take part in many CVD clinical trials Use of DPP-4 inhibitors associated with increased risk of IBD Metformin doesn ’t help HbA1c in teens with type 1 diabetes (Source: OnMedica Latest News)
Source: OnMedica Latest News - December 4, 2018 Category: UK Health Source Type: news

Adding Metformin to Tamoxifen to Protect the Endometrium Adding Metformin to Tamoxifen to Protect the Endometrium
Might the addition of metformin help mitigate the endometrial effects of tamoxifen therapy?Clinical Endocrinology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 3, 2018 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news

Metformin and Risk of HCC in Patients With T2DM Metformin and Risk of HCC in Patients With T2DM
Is metformin use associated with a reduced risk of hepatocellular carcinoma in patients with type 2 diabetes mellitus?Liver International (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 3, 2018 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Metformin's Effect in Diabetes Linked to Gut Microbiota Changes Metformin's Effect in Diabetes Linked to Gut Microbiota Changes
New research links changes in gut microbiota and intestinal farnesoid X receptor with metformin's clinical benefits in diabetes.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 29, 2018 Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news

No link between pancreatic diseases and incretins in type-2 diabetes
Research, published inDiabetic Medicine, suggests that incretins do not increase the risk of pancreatic diseases in type-2 diabetes patients treated with metformin.Healio (Source: Society for Endocrinology)
Source: Society for Endocrinology - November 29, 2018 Category: Endocrinology Source Type: news

Detection of vitamin B12 deficiency in type-2 diabetes patients may lower nerve damage risk
Research, presented at the Society for Endocrinology annual conference, suggests that screening for vitamin B12 deficiency in type-2 diabetes patients, treated with metformin, can reduce their risk of developing nerve damage.Science Daily (Source: Society for Endocrinology)
Source: Society for Endocrinology - November 23, 2018 Category: Endocrinology Source Type: news

Improved Mobility With Metformin in Myotonic Dystrophy Type 1 Improved Mobility With Metformin in Myotonic Dystrophy Type 1
This Phase II RCT showed promise for metformin for improving the mobility of patients with myotonic dystrophy type 1, the most common form of muscular dystrophy in adults.Brain (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 14, 2018 Category: Consumer Health News Tags: Neurology & Neurosurgery Journal Article Source Type: news

Segluromet (Ertugliflozin and Metformin Hydrochloride Tablets) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - November 8, 2018 Category: Drugs & Pharmacology Source Type: news

Metformin Tied to Lower Gastric Cancer Risk After H. Pylori Eradication Metformin Tied to Lower Gastric Cancer Risk After H. Pylori Eradication
Metformin use is associated with a lower risk of gastric cancer in diabetic patients after eradication of H. pylori, researchers from Hong Kong report.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 7, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Medical News Today: Can you eat grapefruit while taking metformin?
Consuming grapefruit or grapefruit juice can affect the safety and effectiveness of a variety of drugs. However, there is little evidence to suggest people taking metformin should avoid grapefruit. Learn more. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - November 7, 2018 Category: Consumer Health News Tags: Diabetes Type 2 Source Type: news

Insulin and metformin may lower severity of Alzheimer ’s disease
Research, published inPLOS One, suggests that insulin and metformin may preserve blood vessels in the brain, lowering the severity of Alzheimer’s disease.Daily Mail  (Source: Society for Endocrinology)
Source: Society for Endocrinology - November 2, 2018 Category: Endocrinology Source Type: news

World Diabetes Day
14 November is World Diabetes Day, which is an annual campaign increase awareness of the diseaseWorld Diabetes Day, on the 14th November every year. The theme for World Diabetes Day 2018 is The Family and Diabetes. The aim is to raise awareness of the impact that diabetes has on the family and support network of those affected, as well as promoting the role of the family in the management, care, prevention and education of diabetes.The Cochrane Metabolic and Endocrine Disorders group's main area of work is the evaluation of the effects of health-care interventions relevant to the prevention, treatment or management, and re...
Source: Cochrane News and Events - November 1, 2018 Category: Information Technology Authors: Muriah Umoquit Source Type: news

Diabetes drugs can reduce the severity of Alzheimer's
Examining blood vessels in the brains of people with both conditions, Icahn School of Medicine researchers found those of people treated with metformin and other drugs were in a better state. (Source: the Mail online | Health)
Source: the Mail online | Health - November 1, 2018 Category: Consumer Health News Source Type: news

Treatment of hypertension for low-risk patients questioned
Study funds little evidence of benefits from treatment Related items fromOnMedica Withdrawn valsartan meds not linked to short-term cancer risk Avoid BP-lowering drugs in stroke Adding insulin to metformin linked to higher mortality Stroke rate higher in HIV patients Recurrent stroke more likely at very low BP (Source: OnMedica Latest News)
Source: OnMedica Latest News - November 1, 2018 Category: UK Health Source Type: news

Metformin lowers age-related macular degeneration risk
Research, presented at the American Academy of Ophthalmology Meeting, suggests that patients with type-2 diabetes who use metformin lower their risk of developing age-related macular degeneration. Med Page Today (Source: Society for Endocrinology)
Source: Society for Endocrinology - October 29, 2018 Category: Endocrinology Source Type: news